Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Naoko Waseda"'
Autor:
Asako Tsunemi, Junko Sato, Mika Kurita, Yuka Wakabayashi, Naoko Waseda, Mami Koshibu, Mai Shinohara, Atsuko Ozaki, Hiromi Nakamura, Naomi Hirano, Fuki Ikeda, Hiroaki Satoh, Hirotaka Watada
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1564-1569 (2020)
Abstract Aims/Introduction In Japan, an insulin pump with predictive low‐glucose management (PLGM) was launched in 2018. It automatically suspends insulin delivery when the sensor detects or predicts low glucose values. The aim of this study was to
Externí odkaz:
https://doaj.org/article/7c2da5894e044842868e190e4e3fb2c1
Autor:
Mami Koshibu, Naomi Hirano, Hiroaki Satoh, Naoko Waseda, Fuki Ikeda, Asako Tsunemi, Mika Kurita, Junko Sato, Yuka Wakabayashi, Atsuko Ozaki, Hiromi Nakamura, Mai Shinohara, Hirotaka Watada
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1564-1569 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction In Japan, an insulin pump with predictive low‐glucose management (PLGM) was launched in 2018. It automatically suspends insulin delivery when the sensor detects or predicts low glucose values. The aim of this study was to analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d878cede78f2ed52275357882d18dd
https://doi.org/10.1111/jdi.13288
https://doi.org/10.1111/jdi.13288
Autor:
Yuka Wakabayashi, Asako Tsunemi, Atsuko Ozaki, Hiromi Nakamura, Junko Sato, Mami Koshibu, Hirotaka Watada, Mai Shinohara, Mika Kurita, Naomi Hirano, Fuki Ikeda, Naoko Waseda
Publikováno v:
Diabetes. 68
Background and Objective: Sensor-augmented pumps (SAP) that suspend insulin when glucose is low or predicted to go low within the next 30 minutes (The MiniMed™ 640G insulin pump) have been approved in Japan from March 2018. The system, Smart GuardT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dec4eed4dcec34fda8a535a87539600
https://doi.org/10.2337/db19-2316-pub
https://doi.org/10.2337/db19-2316-pub
Publikováno v:
Diabetes. 67
SGLT2 inhibitors lower blood glucose levels by inhibiting renal glucose reabsorption independently of insulin action. In addition, SGLT2 inhibitors are known to enhance endogenous glucose production by increasing glucagon level, despite lowering fast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33585e7a3d3765086166e6dd0bd7abdd
https://doi.org/10.2337/db18-1187-p
https://doi.org/10.2337/db18-1187-p
Autor:
Hajime Nawata, Naoko Waseda, Ryoichi Takayanagi, Yoshihiro Nishi, Yi-Ming Mu, Atsushi Tanaka, Toshihiko Yanase, Tanaka Oda
Publikováno v:
Biochemical and Biophysical Research Communications. 271:710-713
Ovarian granulosa cells synthesize estrogens from androgens, which are catalyzed by aromatase cytochrome P450 (P450arom). Troglitazone (Tro), one of the insulin-sensitizing compounds, thiazolidinediones (TZDs), is a ligand for peroxisome proliferator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c83534ba9b550c6fb191e0a0bc5839
https://doi.org/10.1006/bbrc.2000.2701
https://doi.org/10.1006/bbrc.2000.2701